Clinical trial
A Study of Duloxetine in the Treatment of Fibromyalgia
NCT00125892 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00125892 |
|---|---|
| Title | A Study of Duloxetine in the Treatment of Fibromyalgia |
| Official title | A 1-Year Safety Study of Duloxetine in Patients With Fibromyalgia Syndrome |
| Lead sponsor | Eli Lilly and Company, Industry |
| Collaborators | Boehringer Ingelheim Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Fibromyalgia |
| Intervention type | Drug |
| Interventions | duloxetine |
| Enrollment | 320 |
| Start date | Jul 1, 2005 |
| Completion | Mar 1, 2007 |
| First posted | Aug 2, 2005 |
| Last update posted | May 17, 2007 |
| Countries | Argentina, Australia, Brazil, Canada, Mexico, Poland, Taiwan |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: